albuterol has been researched along with Hyperkalemia in 75 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of inhaled albuterol for treatment of hyperkalemia in premature neonates by conducting a prospective, randomized placebo-controlled and double-blinded clinical trial." | 9.10 | Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. ( Keenan, WJ; Noguchi, A; Sadiq, HF; Singh, BS, 2002) |
| "To determine the efficacy and safety of nebulized albuterol in the acute treatment of hyperkalemia in patients on chronic hemodialysis." | 9.06 | Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. ( Allon, M; Copkney, C; Dunlay, R, 1989) |
| "A 4-year-old neutered male Greyhound was presented for albuterol toxicosis leading to severe hypokalemia and respiratory paralysis." | 8.02 | Acute nontraumatic rhabdomyolysis in a Greyhound after albuterol toxicosis. ( Granfone, M; Walker, JM, 2021) |
| "Propranolol treatment was recently reported to be successful for the management of severe infantile hemangioma." | 7.76 | Hyperkalemia complicating propranolol treatment of an infantile hemangioma. ( Kietz, S; Lakomek, M; Lauerer, P; Pavlakovic, H; Zutt, M, 2010) |
| " Intensive exercise also increases the level of circulating catecholamines and lactic acid, which both have been shown to alleviate the depressing effect of hyperkalemia in slow-twitch muscles." | 7.73 | Effects of lactic acid and catecholamines on contractility in fast-twitch muscles exposed to hyperkalemia. ( Clausen, T; Hansen, AK; Nielsen, OB, 2005) |
| "Emergency department (ED) treatment of hyperkalemia often involves shifting potassium into the intracellular space." | 5.48 | Is Transcellular Potassium Shifting With Insulin, Albuterol, or Sodium Bicarbonate in Emergency Department Patients With Hyperkalemia Associated With Recurrent Hyperkalemia After Dialysis? ( Cales, EK; Chittineni, C; Driver, BE; Klein, LR; Scott, N, 2018) |
| "To evaluate the efficacy of inhaled albuterol for treatment of hyperkalemia in premature neonates by conducting a prospective, randomized placebo-controlled and double-blinded clinical trial." | 5.10 | Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates. ( Keenan, WJ; Noguchi, A; Sadiq, HF; Singh, BS, 2002) |
| "To determine the efficacy and safety of nebulized albuterol in the acute treatment of hyperkalemia in patients on chronic hemodialysis." | 5.06 | Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. ( Allon, M; Copkney, C; Dunlay, R, 1989) |
| "In fifteen patients with hyperkalaemic familial periodic paralysis, inhalation of salbutamol alleviated hyperkaleamia and paralysis precipitated by exercise or oral administration of potassium chloride." | 5.04 | Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. ( Clausen, T; Wang, P, 1976) |
| "Albuterol by inhalation (IH) is a common treatment for hyperkalemia in humans but its effect on blood potassium concentrations in dogs is unknown." | 4.12 | Effect of inhaled albuterol on whole blood potassium concentrations in dogs. ( Acierno, M; Costa, RS; da Cunha, A; Jaffey, JA; Jones, T; Kreisler, R; Ogrodny, A; Westerback, E, 2022) |
| "A 4-year-old neutered male Greyhound was presented for albuterol toxicosis leading to severe hypokalemia and respiratory paralysis." | 4.02 | Acute nontraumatic rhabdomyolysis in a Greyhound after albuterol toxicosis. ( Granfone, M; Walker, JM, 2021) |
| "Propranolol treatment was recently reported to be successful for the management of severe infantile hemangioma." | 3.76 | Hyperkalemia complicating propranolol treatment of an infantile hemangioma. ( Kietz, S; Lakomek, M; Lauerer, P; Pavlakovic, H; Zutt, M, 2010) |
| " Intensive exercise also increases the level of circulating catecholamines and lactic acid, which both have been shown to alleviate the depressing effect of hyperkalemia in slow-twitch muscles." | 3.73 | Effects of lactic acid and catecholamines on contractility in fast-twitch muscles exposed to hyperkalemia. ( Clausen, T; Hansen, AK; Nielsen, OB, 2005) |
| "In order to evaluate the efficiency of albuterol sulfate (salbutamol) in lowering of potassium levels in uremic children with hyperkalemia, we intravenously administered salbutamol 30 micrograms/min (total doses 0." | 3.67 | [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency]. ( Arias-Reyes, JA; Dubey-Ortega, LA; Matos-Martínez, M; Velásquez-Jones, L, 1989) |
| "Hyperkalemia is a risky and potentially life-threatening condition in pre-term infants." | 2.90 | Nebulized salbutamol diminish the blood glucose fluctuation in the treatment of non-oliguric hyperkalemia of premature infants. ( Chen, JY; Chiu, CD; Chiu, YP; Ji, HR; Saw, HP, 2019) |
| "Seventeen chronic renal failure patients referred to the Nephrology Unit between October 1, 1997 and March 31, 1998 for hemodialysis were randomized." | 2.69 | Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe? ( Gilad, E; Houri, S; Krupnik, Z; Mandelberg, A; Matas, Z; Priel, IE; Smetana, S, 1999) |
| "Acute treatment of hyperkalemia in patients with end-stage renal disease requires temporizing measures to shift potassium rapidly from the extracellular to the intracellular fluid compartments until hemodialysis can be initiated." | 2.68 | Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. ( Allon, M; Shanklin, N, 1996) |
| "Ten patients with acute and 60 with chronic renal failure (both groups having hyperkalaemia), were managed at Kenyatta National Hospital in the medical wards and Renal Unit between August, 1995 and January, 1996." | 2.68 | Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. ( Kayima, JK; McLigeyo, SO; Ngugi, NN, 1997) |
| "Hyperkalemia is one of the frequent medical emergencies in patients with chronic renal failure (CRF)." | 2.67 | Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. ( Chiang, SS; Huang, TP; Liou, HH; Wu, SC; Yang, WC, 1994) |
| "Three groups of patients with acute or chronic renal failure (GFR less than 5 ml/min) and hyperkalaemia (K+ greater than or equal to 6 mEq/l), similar in age, serum creatinine and pretreatment K+." | 2.66 | Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. ( Campistol, JM; Cases, A; Lens, XM; Montoliu, J; Revert, L, 1989) |
| " Recent investigations also suggest that the optimal dosing of intravenous insulin may be lower than previously described." | 2.61 | Acute Management of Hyperkalemia. ( Liu, M; Rafique, Z, 2019) |
| "When the decision for urgent treatment of hyperkalemia is based on EKG changes, an important caveat for clinicians is that absent or atypical EKG changes do not exclude the necessity for immediate intervention." | 2.41 | Therapeutic approach to hyperkalemia. ( Han, SW; Kim, HJ, 2002) |
| "Hyperkalemia is a life threatening emergency and warrants immediate treatment because of its deleterious cardiac consequences." | 2.39 | Hyperkalemia: therapeutic options in acute and chronic renal failure. ( Harps, E; Kemper, MJ; Müller-Wiefel, DE, 1996) |
| " The initially used intravenous dosage (0." | 2.38 | [The treatment of hyperkalemia with salbutamol]. ( Muñoz, R; Velásquez, L, 1991) |
| "Emergency department (ED) treatment of hyperkalemia often involves shifting potassium into the intracellular space." | 1.48 | Is Transcellular Potassium Shifting With Insulin, Albuterol, or Sodium Bicarbonate in Emergency Department Patients With Hyperkalemia Associated With Recurrent Hyperkalemia After Dialysis? ( Cales, EK; Chittineni, C; Driver, BE; Klein, LR; Scott, N, 2018) |
| "Propranolol has been reported to be used as a successful treatment of severe symptomatic infantile haemangiomas." | 1.40 | A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis. ( Belen, B; Dalgic, B; Oguz, A; Okur, A, 2014) |
| "Almost all the patients were treated for hyperkalemia." | 1.40 | Management of hyperkalemia in hospitalized patients. ( Doran, JJ; Fordjour, KN; Walton, T, 2014) |
| "Acute hyperkalemia is a frequent, potentially life-threatening complication in orthotopic liver transplantation (OLT)." | 1.35 | Salbutamol to facilitate management of acute hyperkalemia in liver transplantation: a case report. ( Chang, SH; Kim, DK; Kwon, WK; Woo, NS; Yun, IJ, 2009) |
| "Fourteen children with chronic renal failure, three with acute renal failure and hyperkalemia were treated by intravenous infusions of 4 micrograms/kg salbutamol." | 1.29 | Treatment of hyperkalemia in children with intravenous salbutamol. ( Anarat, A; Noyan, A; Pirti, M; Yurdakul, Z, 1995) |
| "No arrhythmia was seen during the hypokalaemic phase." | 1.29 | The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. ( Brandt, HD; Du Plooy, WJ; Hay, L; Kahler, CP; Schutte, PJ, 1994) |
| "Seven infants had acute renal failure, two had persistent metabolic acidosis without renal failure and the remaining infant had a combination of acute renal failure and persistent metabolic acidosis." | 1.28 | Salbutamol infusion to treat neonatal hyperkalaemia. ( Brooker, R; Emery, EF; Gamsu, HR; Greenough, A, 1992) |
| "Salbutamol was administered intravenously to 5 patients with renal function impairment for estimation its pharmacokinetic parameters." | 1.28 | Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects. ( Luquel, L; Mory, B; Offenstadt, G; Olive, G; Rey, E; Richard, MO, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (21.33) | 18.7374 |
| 1990's | 25 (33.33) | 18.2507 |
| 2000's | 17 (22.67) | 29.6817 |
| 2010's | 14 (18.67) | 24.3611 |
| 2020's | 3 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogrodny, A | 1 |
| Jaffey, JA | 1 |
| Kreisler, R | 1 |
| Acierno, M | 1 |
| Jones, T | 1 |
| Costa, RS | 1 |
| da Cunha, A | 1 |
| Westerback, E | 1 |
| Montassier, E | 2 |
| Lemoine, L | 1 |
| Hardouin, JB | 1 |
| Rossignol, P | 2 |
| Legrand, M | 2 |
| Granfone, M | 1 |
| Walker, JM | 1 |
| Driver, BE | 1 |
| Klein, LR | 1 |
| Chittineni, C | 1 |
| Cales, EK | 1 |
| Scott, N | 1 |
| Potel, G | 1 |
| Saw, HP | 1 |
| Chiu, CD | 1 |
| Chiu, YP | 1 |
| Ji, HR | 1 |
| Chen, JY | 1 |
| Liu, M | 1 |
| Rafique, Z | 1 |
| Cetin, N | 1 |
| Yildiz, B | 1 |
| Kural, N | 1 |
| Maxwell, AP | 1 |
| Linden, K | 1 |
| O'Donnell, S | 1 |
| Hamilton, PK | 1 |
| McVeigh, GE | 1 |
| Ringer, M | 1 |
| Pulfrey, S | 1 |
| Belen, B | 1 |
| Oguz, A | 1 |
| Okur, A | 1 |
| Dalgic, B | 1 |
| Sánchez-Velázquez, P | 1 |
| Castellví, Q | 1 |
| Villanueva, A | 1 |
| Quesada, R | 1 |
| Pañella, C | 1 |
| Cáceres, M | 1 |
| Dorcaratto, D | 1 |
| Andaluz, A | 1 |
| Moll, X | 1 |
| Trujillo, M | 1 |
| Burdío, JM | 1 |
| Berjano, E | 1 |
| Grande, L | 1 |
| Ivorra, A | 1 |
| Burdío, F | 1 |
| Effa, E | 1 |
| Webster, A | 1 |
| Neary, B | 1 |
| Colovic, V | 1 |
| Kim, DK | 1 |
| Chang, SH | 1 |
| Yun, IJ | 1 |
| Kwon, WK | 1 |
| Woo, NS | 1 |
| Sieber, U | 1 |
| Escher, R | 1 |
| Wallmann, D | 1 |
| Somes, J | 1 |
| Donatelli, NS | 1 |
| Pavlakovic, H | 1 |
| Kietz, S | 1 |
| Lauerer, P | 1 |
| Zutt, M | 1 |
| Lakomek, M | 1 |
| Vemgal, P | 2 |
| Ohlsson, A | 2 |
| Fordjour, KN | 1 |
| Walton, T | 1 |
| Doran, JJ | 1 |
| Mildenberger, E | 1 |
| Versmold, HT | 1 |
| Kim, HJ | 2 |
| Han, SW | 1 |
| Lexchin, J | 1 |
| Celik, S | 1 |
| Bal, R | 1 |
| Durgut, R | 1 |
| Hansen, AK | 1 |
| Clausen, T | 4 |
| Nielsen, OB | 1 |
| Ostovar, H | 1 |
| Jones, J | 1 |
| Brown, M | 1 |
| Mahoney, BA | 1 |
| Smith, WA | 1 |
| Lo, DS | 1 |
| Tsoi, K | 1 |
| Tonelli, M | 1 |
| Clase, CM | 1 |
| Indik, JH | 1 |
| O'Hare, FM | 1 |
| Molloy, EJ | 1 |
| Yaseen, H | 1 |
| Khalaf, M | 1 |
| Dana, A | 1 |
| Yaseen, N | 1 |
| Darwich, M | 1 |
| Bushe, C | 1 |
| Wang, P | 3 |
| Orskov, H | 2 |
| Kristensen, O | 1 |
| Noyan, A | 1 |
| Anarat, A | 1 |
| Pirti, M | 1 |
| Yurdakul, Z | 1 |
| Wheeldon, NM | 1 |
| McDevitt, DG | 1 |
| Lipworth, BJ | 1 |
| Du Plooy, WJ | 1 |
| Hay, L | 1 |
| Kahler, CP | 1 |
| Schutte, PJ | 1 |
| Brandt, HD | 1 |
| Liou, HH | 2 |
| Chiang, SS | 2 |
| Wu, SC | 2 |
| Yang, WC | 2 |
| Huang, TP | 2 |
| McClure, RJ | 1 |
| Prasad, VK | 1 |
| Brocklebank, JT | 1 |
| Campese, VM | 1 |
| Smogorzewski, M | 1 |
| Rambausek, M | 1 |
| Kluge, R | 1 |
| Mocan, MZ | 1 |
| Mocan, G | 1 |
| Mocan, H | 1 |
| Gorçin, B | 1 |
| Kemper, MJ | 2 |
| Harps, E | 2 |
| Hellwege, HH | 1 |
| Müller-Wiefel, DE | 2 |
| Allon, M | 3 |
| Shanklin, N | 1 |
| Semmekrot, BA | 1 |
| Monnens, LA | 1 |
| Ngugi, NN | 1 |
| McLigeyo, SO | 1 |
| Kayima, JK | 1 |
| Hanna, MG | 1 |
| Stewart, J | 1 |
| Schapira, AH | 1 |
| Wood, NW | 1 |
| Morgan-Hughes, JA | 1 |
| Murray, NM | 1 |
| Wong, SL | 1 |
| Maltz, HC | 1 |
| Mandelberg, A | 1 |
| Krupnik, Z | 1 |
| Houri, S | 1 |
| Smetana, S | 1 |
| Gilad, E | 1 |
| Matas, Z | 1 |
| Priel, IE | 1 |
| Ahee, P | 1 |
| Crowe, AV | 1 |
| Helfrich, E | 1 |
| de Vries, TW | 1 |
| van Roon, EN | 1 |
| Singh, BS | 1 |
| Sadiq, HF | 1 |
| Noguchi, A | 1 |
| Keenan, WJ | 1 |
| Harris, DM | 1 |
| Salway, JG | 1 |
| Greenough, A | 1 |
| Emery, EF | 1 |
| Brooker, R | 1 |
| Gamsu, HR | 1 |
| Leanza, HJ | 1 |
| Rivarola, G | 1 |
| Graciela García, M | 1 |
| Najun Zarazaga, CJ | 1 |
| Casadei, D | 1 |
| Dilmen, U | 1 |
| Toppare, M | 1 |
| Senses, DA | 1 |
| Kaya, IS | 1 |
| Velásquez, L | 1 |
| Muñoz, R | 1 |
| Murdoch, IA | 1 |
| Dos Anjos, R | 1 |
| Haycock, GB | 1 |
| Verocay, C | 1 |
| Grünberg, J | 1 |
| Copkney, C | 2 |
| Montoliu, J | 3 |
| Almirall, J | 1 |
| Ponz, E | 1 |
| Campistol, JM | 2 |
| Revert, L | 3 |
| Lens, XM | 2 |
| Cases, A | 1 |
| de Cornelissen, F | 1 |
| Bermudes, H | 1 |
| Saint-Loubert, M | 1 |
| Marty, L | 1 |
| Emond, C | 1 |
| Fontanier, P | 1 |
| Dracon, M | 1 |
| Delvallez, L | 1 |
| Noel, C | 1 |
| Lelièvre, G | 1 |
| Tacquet, A | 1 |
| Rey, E | 1 |
| Luquel, L | 1 |
| Richard, MO | 1 |
| Mory, B | 1 |
| Offenstadt, G | 1 |
| Olive, G | 1 |
| Arias-Reyes, JA | 1 |
| Matos-Martínez, M | 1 |
| Velásquez-Jones, L | 1 |
| Dubey-Ortega, LA | 1 |
| Dunlay, R | 1 |
| Djurhuus, S | 1 |
| Rohold, A | 1 |
| Medici, R | 1 |
| Vadstrup, S | 1 |
| Lockwood, RH | 1 |
| Lum, BK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| InSaKa Trial: Insulin Dextrose Infusion Versus Nebulized Salbutamol Versus Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia: a Randomized Clinical Trial[NCT04012138] | Phase 4 | 525 participants (Anticipated) | Interventional | 2019-12-20 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for albuterol and Hyperkalemia
| Article | Year |
|---|---|
Acute Management of Hyperkalemia.
Topics: Acute Disease; Albuterol; Calcium; Diuretics; Humans; Hyperkalemia; Insulin; Polymers; Potassium; Si | 2019 |
Management of hyperkalaemia.
Topics: Albuterol; Arrhythmias, Cardiac; Drug Therapy, Combination; Emergency Treatment; Glucose; Humans; Hy | 2013 |
Pharmacological interventions for the management of acute hyperkalaemia in adults.
Topics: Acute Disease; Adult; Albuterol; Biomarkers; Chi-Square Distribution; Down-Regulation; Glucose; Huma | 2017 |
Interventions for non-oliguric hyperkalaemia in preterm neonates.
Topics: Albuterol; Glucose; Humans; Hyperkalemia; Infant, Newborn; Infant, Premature; Infant, Premature, Dis | 2012 |
Pathogenesis and therapy of non-oliguric hyperkalaemia of the premature infant.
Topics: Adrenergic beta-Agonists; Albuterol; Calcium; Diuretics; Evidence-Based Medicine; Exchange Transfusi | 2002 |
Therapeutic approach to hyperkalemia.
Topics: Adrenergic beta-Agonists; Albuterol; Calcium; Digestive System; Drug Therapy, Combination; Electroca | 2002 |
Best evidence topic report. Nebulised levalbuterol or albuterol for lowering serum potassium.
Topics: Adrenergic beta-Agonists; Albuterol; Emergencies; Evidence-Based Medicine; Humans; Hyperkalemia; Neb | 2005 |
Emergency interventions for hyperkalaemia.
Topics: Adrenergic beta-Agonists; Albuterol; Bicarbonates; Emergency Treatment; Glucose; Humans; Hyperkalemi | 2005 |
Interventions for non-oliguric hyperkalaemia in preterm neonates.
Topics: Albuterol; Glucose; Humans; Hyperkalemia; Infant, Newborn; Infant, Premature; Infant, Premature, Dis | 2007 |
What is the best treatment for hyperkalaemia in a preterm infant?
Topics: Albuterol; Calcium Gluconate; Evidence-Based Medicine; Exchange Transfusion, Whole Blood; Humans; Hy | 2008 |
Hyperkalemia: therapeutic options in acute and chronic renal failure.
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Adrenergic beta-Agonists; Albuterol; Child; Child, P | 1996 |
Albuterol for the treatment of hyperkalemia.
Topics: Adrenergic beta-Agonists; Albuterol; Clinical Trials as Topic; Humans; Hyperkalemia | 1999 |
Salbutamol for hyperkalaemia in children.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Child; Child, Preschool | 2001 |
Drug interference causing misinterpretation of laboratory results. How to solve the problem.
Topics: Albuterol; Biochemistry; Clinical Laboratory Techniques; Computers; Drug-Related Side Effects and Ad | 1978 |
[The treatment of hyperkalemia with salbutamol].
Topics: Albuterol; Humans; Hyperkalemia; Kidney; Potassium; Receptors, Adrenergic | 1991 |
14 trials available for albuterol and Hyperkalemia
| Article | Year |
|---|---|
Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA).
Topics: Albuterol; Emergency Service, Hospital; Glucose; Humans; Hyperkalemia; Insulin; Multicenter Studies | 2020 |
Nebulized salbutamol diminish the blood glucose fluctuation in the treatment of non-oliguric hyperkalemia of premature infants.
Topics: Albuterol; Blood Glucose; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Hyperkalemia; Inf | 2019 |
Experimental hyperkalaemia in rabbits: effects of salbutamol and norepinephrine treatments on blood biochemistry and electrocardiography.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Alanine Transaminase; Albuterol; Animals; Aspar | 2003 |
The effects of lower than conventional doses of oral nadolol on relative beta 1/beta 2-adrenoceptor blockade.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists | 1994 |
Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure.
Topics: Administration, Inhalation; Aged; Albuterol; Female; Humans; Hyperkalemia; Infusions, Intravenous; K | 1994 |
Inhaler salbutamol for acute hyperkalemia in renal failure.
Topics: Acute Disease; Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Drug Therapy, | 1993 |
Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Cross-Over Studies; Drug Synergism; Female; Humans | 1996 |
Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
Topics: Acute Kidney Injury; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol | 1997 |
Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Double-Blind Method; Female; | 1999 |
Efficacy of albuterol inhalation in treatment of hyperkalemia in premature neonates.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Double-Blind Method; Female; Humans | 2002 |
Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol.
Topics: Adolescent; Adult; Aerosols; Albuterol; Animals; Clinical Trials as Topic; Epinephrine; Humans; Hype | 1976 |
Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.
Topics: Administration, Inhalation; Aerosols; Albuterol; Drug Therapy, Combination; Glucose; Humans; Hyperka | 1990 |
Treatment of hyperkalaemia in renal failure: salbutamol v. insulin.
Topics: Acute Kidney Injury; Aged; Albuterol; Drug Therapy, Combination; Electrocardiography; Female; Humans | 1989 |
Nebulized albuterol for acute hyperkalemia in patients on hemodialysis.
Topics: Acute Disease; Adult; Aerosols; Aged; Albuterol; Blood Pressure; Double-Blind Method; Drug Evaluatio | 1989 |
46 other studies available for albuterol and Hyperkalemia
| Article | Year |
|---|---|
Effect of inhaled albuterol on whole blood potassium concentrations in dogs.
Topics: Albuterol; Animals; Blood Glucose; Dog Diseases; Dogs; Humans; Hyperkalemia; Potassium; Prospective | 2022 |
Acute nontraumatic rhabdomyolysis in a Greyhound after albuterol toxicosis.
Topics: Acute Kidney Injury; Albuterol; Animals; Dog Diseases; Dogs; Hyperkalemia; Hypokalemia; Male; Rhabdo | 2021 |
Is Transcellular Potassium Shifting With Insulin, Albuterol, or Sodium Bicarbonate in Emergency Department Patients With Hyperkalemia Associated With Recurrent Hyperkalemia After Dialysis?
Topics: Albuterol; Dialysis; Emergency Service, Hospital; Female; Humans; Hyperkalemia; Insulin; Male; Middl | 2018 |
Hyperkalemia in the emergency department: Consider the use of nebulized salbutamol.
Topics: Albuterol; Emergency Service, Hospital; Humans; Hyperkalemia; Hypoglycemia; Insulin; Nebulizers and | 2019 |
Hyperkalemia in children with nephrotic syndrome.
Topics: Administration, Inhalation; Albuterol; Biomarkers; Child; Child, Preschool; Combined Modality Therap | 2013 |
Runner's new diet, his collapse, and his ECG: when a rapid ECG diagnosis can save the day.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Antihypertensive Agents; Calcium Gluconate; Dietary | 2014 |
A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis.
Topics: Albuterol; Angiography; Biopsy, Needle; Drug Therapy, Combination; Fluid Therapy; Follow-Up Studies; | 2014 |
Irreversible electroporation of the liver: is there a safe limit to the ablation volume?
Topics: Albuterol; Animals; Cell Membrane Permeability; Electrochemotherapy; Furosemide; Hyperkalemia; Liver | 2016 |
Perioperative management of a hyperkalemic infant.
Topics: Adrenergic beta-Agonists; Albuterol; Anuria; Bicarbonates; Buffers; Critical Care; Humans; Hyperkale | 2009 |
Salbutamol to facilitate management of acute hyperkalemia in liver transplantation: a case report.
Topics: Acute Disease; Adrenergic beta-Agonists; Albuterol; Humans; Hyperkalemia; Intraoperative Complicatio | 2009 |
[What is your diagnosis? Hyperkalemia in acute kidney failure in known chronic kidney failure].
Topics: Acute Kidney Injury; Aged; Albuterol; Bronchodilator Agents; Calcium Gluconate; Critical Care; Elect | 2009 |
A geriatric patient with medication-mediated profound weakness.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Anti-Arrhythmia Agents; Anticonvulsants; Antihyperte | 2010 |
Hyperkalemia complicating propranolol treatment of an infantile hemangioma.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Female; Fluid Therapy; | 2010 |
Management of hyperkalemia in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuterol; Calcium; Cation Exchange Resins; Dose-Respons | 2014 |
Treating hyperkalaemia.
Topics: Administration, Inhalation; Albuterol; Bronchodilator Agents; Humans; Hyperkalemia; Nebulizers and V | 2003 |
Effects of lactic acid and catecholamines on contractility in fast-twitch muscles exposed to hyperkalemia.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Calcitonin Gene-Related Peptide; Epinephrine; Female; | 2005 |
A pointed clue.
Topics: Acute Kidney Injury; Adult; Albuterol; Bicarbonates; Bundle-Branch Block; Calcium Gluconate; Cation | 2005 |
Salbutamol versus cation-exchange resin (kayexalate) for the treatment of nonoliguric hyperkalemia in preterm infants.
Topics: Adrenergic beta-Agonists; Albuterol; Cation Exchange Resins; Female; Humans; Hyperkalemia; Infant, N | 2008 |
Salbutamol for hyperkalaemia.
Topics: Albuterol; Humans; Hyperkalemia | 1983 |
Hyperkalemic periodic paralysis. Relationships between changes in plasma water, electrolytes, insulin and catecholamines during attacks.
Topics: Albuterol; Blood Glucose; Blood Proteins; Body Water; Catecholamines; Chlorides; Electrolytes; Gluca | 1980 |
Treatment of hyperkalemia in children with intravenous salbutamol.
Topics: Albuterol; Blood Glucose; Child; Female; Humans; Hyperkalemia; Infant; Infusions, Intravenous; Male; | 1995 |
The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential.
Topics: Albuterol; Animals; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Electroc | 1994 |
Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
Topics: Administration, Intranasal; Adolescent; Albuterol; Child; Child, Preschool; Humans; Hyperkalemia; In | 1994 |
Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.
Topics: Administration, Inhalation; Aged; Albuterol; Analysis of Variance; Female; Humans; Hyperkalemia; Inf | 1994 |
[beta-Sympathomimetics against hyperkalemia in kidney failure].
Topics: Administration, Inhalation; Albuterol; Humans; Hyperkalemia; Kidney Failure, Chronic; Renal Dialysis | 1993 |
Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol.
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Child; Child, Preschool; Combined Modality Therapy; | 1996 |
Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Blood Pressure; Drug Therapy, Combination; Female; Heart | 1997 |
A warning for the treatment of hyperkalaemia with salbutamol.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Arrhythmias, Cardiac; Child; Humans; Hyperkalemia; Pap | 1997 |
Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A).
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Chromosomes, Human, Pair 17; DNA Mutational Analysis; El | 1998 |
The management of hyperkalaemia in the emergency department.
Topics: Adrenergic beta-Agonists; Albuterol; Calcium Gluconate; Emergency Service, Hospital; Emergency Treat | 2000 |
Letter: Salbutamol in hyperkalaemic familial periodic paralysis.
Topics: Albuterol; Humans; Hyperkalemia; Paralyses, Familial Periodic | 1976 |
Salbutamol inhalations suppress attacks of hyperkalemia in familial periodic paralysis.
Topics: Albuterol; Blood Glucose; Humans; Hyperkalemia; Insulin; Muscles; Paralyses, Familial Periodic | 1978 |
Salbutamol infusion to treat neonatal hyperkalaemia.
Topics: Acidosis; Acute Kidney Injury; Albuterol; Female; Humans; Hyperkalemia; Infant, Low Birth Weight; In | 1992 |
[Rapid correction of acute hyperkalemia with nebulized salbutamol].
Topics: Acute Disease; Administration, Intranasal; Adult; Aged; Albuterol; Female; Hemodynamics; Humans; Hyp | 1992 |
Salbutamol in the treatment of neonatal hyperkalemia.
Topics: Albuterol; Female; Humans; Hyperkalemia; Infant, Newborn; Male | 1992 |
Treatment of hyperkalaemia with intravenous salbutamol.
Topics: Acute Kidney Injury; Albuterol; Female; Humans; Hyperkalemia; Infant; Infant, Newborn; Infusions, In | 1991 |
[Treatment of hyperkalemia using salbutamol].
Topics: Albuterol; Humans; Hyperkalemia | 1990 |
Treatment of hyperkalaemia in renal failure with salbutamol inhalation.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Electrocardiography; Female; | 1990 |
[Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients].
Topics: Albuterol; Humans; Hyperkalemia; Infusions, Intravenous; Kidney Failure, Chronic; Renal Dialysis | 1989 |
[Treatment of hyperkalemia using salbutamol in acute kidney failure].
Topics: Acute Kidney Injury; Adult; Albuterol; Drug Evaluation; Female; Humans; Hyperkalemia; Male; Middle A | 1989 |
Hyperkalaemia--silent and deadly.
Topics: Albuterol; Calcium Gluconate; Electrocardiography; Humans; Hyperkalemia | 1989 |
Pharmacokinetics of intravenous salbutamol in renal insufficiency and its biological effects.
Topics: Acute Kidney Injury; Aged; Albuterol; Female; Heart Rate; Humans; Hyperkalemia; Infusions, Intraveno | 1989 |
[Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency].
Topics: Adolescent; Albuterol; Child; Drug Evaluation; Electrocardiography; Female; Humans; Hyperkalemia; In | 1989 |
[Hyperkalemia precipitated by beta 2 receptor agonists].
Topics: Aged; Albuterol; Asthma; Female; Humans; Hyperkalemia; Terbutaline | 1986 |
Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
Topics: Adult; Aged; Albuterol; Diabetes Mellitus, Type 1; Female; Humans; Hyperkalemia; Kidney Failure, Chr | 1987 |
Effects of adrenergic agonists and antagonists on potassium metabolism.
Topics: Albuterol; Animals; Blood Glucose; Blood Pressure; Butoxamine; Cats; Epinephrine; Ethanolamines; Hea | 1974 |